Can-Fite BioPharma Ltd. Current Assets
Can-Fite BioPharma Ltd. (CANF) had Current Assets of $9.44 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-03-26
- 2025-12-31: Assets, Current $9.44M.
- 2025-06-30: Assets, Current $7.62M.
- 2024-12-31: Assets, Current $8.98M.
- 2024-06-30: Assets, Current $5.83M.
| Period end | Assets, Current |
|---|---|
| 2025-12-31 | $9.44M 20-F · filed 2026-03-26 |
| 2025-06-30 | $7.62M 6-K · filed 2025-08-28 |
| 2024-12-31 | $8.98M 20-F · filed 2026-03-26 |
| 2024-06-30 | $5.83M 6-K · filed 2024-08-29 |
| 2023-12-31 | $9.91M 20-F · filed 2025-04-14 |
| 2023-06-30 | $10.91M 6-K · filed 2023-08-31 |
| 2022-12-31 | $9.16M 20-F · filed 2024-03-28 |
| 2022-06-30 | $14.59M 6-K · filed 2022-08-25 |
| 2021-12-31 | $20.07M 20-F · filed 2023-03-30 |
| 2021-06-30 | $9.55M 6-K · filed 2021-08-26 |
| 2020-12-31 | $9.40M 20-F · filed 2022-03-24 |
| 2020-06-30 | $12.70M 6-K · filed 2020-08-27 |
| 2019-12-31 | $7.14M 20-F · filed 2021-03-25 |
| 2018-12-31 | $7.90M 6-K · filed 2020-06-01 |